Back to mobile site

Sangamo Biosciences, Inc. (SGMO) Tops Q2 EPS by 4c

July 23, 2014 4:48 PM EDT

Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $7.84 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings